You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:
en/glaxosmithkline-astrazeneca-merck-pfizer-other-firms-join-uk-govt-in-committing-to-increased-access-to-essential-medicines-for-poorest-countries-including-via-differential-pricing#c47893

Renewed Commitment to Government – Industry Partnership to Improve Access to Medicines

Author: UK Department for International Development (DFID), Published on: 30 March 2005

The UK Government and the world’s largest pharmaceutical companies today committed to continue to work together to help increase access to essential medicines for the world’s poorest countries...The UK Government’s framework for good practice has been developed with the support and input of the pharmaceutical industry, including GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Inc., Pfizer, the Association of the British Pharmaceutical Industry (ABPI) and the American Pharmaceutical Group (APG)...[which] represents eleven US pharmaceutical companies, including Abbott Laboratories, Amgen, Bristol-Myers Squibb, Chiron Vaccines, Janssen-Cilag Ltd [part of Johnson & Johnson], Lilly [Eli Lilly], Merck Sharp & Dohme, Pfizer, Procter & Gamble Pharmaceuticals, Schering-Plough and Wyeth Pharmaceuticals.

Read the full post here

Related companies: Abbott Laboratories Amgen AstraZeneca Bristol-Myers Squibb Chiron Eli Lilly GlaxoSmithKline Janssen Pharmaceutica (part of Johnson & Johnson) Merck Merck Sharp & Dohme (part of Merck) Pfizer Procter & Gamble Schering-Plough Wyeth (part of Pfizer)